Table 2. GBI-10 interacts with tenascin.

LEELENLVSSLR	126-138
VTEYLVVYTPTHEGGLEMQFR	648-668
SIPVSARVATYLPAPEGLK	700-718
NMNKEDEGEITK	747-758
RPETSYRQTGLAPGQEYEISLHIVKNNTR	762-790
LDAPSQIEVKD	802-812
AKETFTTGLDAPR	884-896
VSQTDNSITL EWR	901-913
TLTGLRPGTEY GIGVSAVK	949-968
GLEPGQEYNVLLTAEK	1,041-1,056
AATPYTVSIYGVIQGY	1,135-1,152
STDLPGLK	1,218-1,125
AVDIPGLEAATPYR	1,400-1,413
TAHISGLPPSTDFIVYLSGL APSIR	1,491-1,515
LSWTADEGVFDNFVLKI	1,637-1,653
KQSEPLEITLLAPER	1,658-1,672
RSQTVSAIATTAMGSPK	1,697-1,713
ITYVPITGGTPSMVTVDGTK	1,741-1,760
WQPAIATVDSYVI SYTGEKVPEITR	1,818-1,842
FTTDLDSPR	1,882-1,890
GRENFYQNWK	2,031-2,040
REEFWLGLDNL NKITAQGQYELRV	2,050-2,073
DHGETAFAVYDKFSVGDAK	2,077-2,095
YGDNNHSQGVNWFHWKGHEHSIQFAEMK	2,156-2,083

GBI-10 affinity-purified peptides identified by LC-MS/MS (column 1) along with their location within tenascin-C (column 2).